ГОСТ Р ИСО 10993-4—2009
(26] DIDISHEIM. Р.. DEWANJEE. М.К.. KAYE. М.Р.. FRISK. C.S., FASS. D.N., TIRRELL, M.V. and ZOLLMAN. P.E..
Nonpredictability of long-term In vivo response from short-term in vitro or ex vivo blood/material interactions. Trans.
Amer. Soc. Artif. Int. Organs. 30. 1984. pp. 370 — 376
(27] DIDISHEIM. P.. OLSEN. D.B.. FARRAR. D.J.. PORTNER. P.M., GRIFFITH. B.P.. PENNINGTON. D.G.. JOIST,
J.H.. SCHOEN. J.F.. GRlSTINA. A.G. and ANDERSON. J.M., Infections and thromboembolism with implantable
cardiovascular devices. Trans. Amer. Soc. Artif. Int. Organs. 35. 1989. pp. 54 — 70
(28] DIDISHEIM. P.. STROPP. J.O., BOROWICK. J.H. and GRABOWSKI. E.F.. Species differences In platelet
adhesion to biomateriats: Investigation by a two-stage technique. Trans. Amer. Soc. Artif. Int. Organs. 2. 1979. pp.
124 — 132
(29] Guidelines for blood/material interactions. Report of the National Heart. Lung and Blood Institute Work«g Group. U
S. Department of Health and Human Services. Public Health Service. National Institutes of Health. NIH
Publication No. 85 — 2185, revised September 1985. Available from Biomatenals Program. Bioengineering
Research Group. Division of Heart and Vascular Diseases. NHLBI. Two Rockledge Center. 6701 Rockledge Drive,
Bethesda. MD 20892. USA
(30] HARKER. L.A., KELLY. A.B. and HANSON. S.R.. Experimental arterial thromboses In non-human primates.
Circulation, 83. Supplement IV. 1991. pp. 41 — 55
(31] HARKER. L.A., MALPASS. T.W.. BRANSON. H E.. HESSEL. E.A. II and SLICHTER. S.J., Mechanism of
abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction
associated with selective alpha granule release. Blood. 56. 1980. pp. 824 — 834
(32] HARKER. L.A.. RATNER. B.D.. and DIDISHEIM. P. (Eds): Cardiovascular Biomatenals and Biocompatibllity.
Supplement to Cardiovasc. Pathol.. 2(3) (Suppl.). Jui-Sept 1993. pp. 1S — 224S
(33] KARWATH. R.. SCHURER. M. and WOLF. H.. Measurement of platelet adhesiveness onto artificial surfaces
using Cr-51 and In-111 labelled platelets. Studla Btophys.. 131.1989. pp. 117 — 123
(34] KATAOKA. K.. MAEDA. M.. NISHIMURA. T.. NlTADORI. TSURUTA. T.. AKAIKE. T., and SAKURAI. Y..
Estimation of cell adhesion on polymer surfaceswith the use of "column method’. J. Biomed. Mater. Res.. 14.
1980. pp. 817 — 823
(35]KAY. L.A., Essentials of Haemostasis and Thrombosis. Churchill Livingstone. Edinburgh. 1988. pp. 290
(36] LEWIS. J.L.. SWEENEY. J.. BALDINI, L., FRIEDLAND. G.H.. and SALZMAN. E.W.. Assessment of throm-
boresistance of Intravenous cannulae by 125 l-fibrmogen scanning. J. Biomed. Mater. Res.. 19. 1985. p. 99
(37] MAHIOUT. A.. MEINHOLD. H.. JORRES, A.. KRIEG. R.. KESSEL.. M „ TRETZEL. J. and BAURMEISTER. U.. Ex
vivo model for preclmlcal evaluation of dialysers containing new membranes. Life Support Systems. 3. Suppl. 1.
1985. pp. 448 — 452
(38]MIALE. J.B.. Laboratory medicine hematology. Sixth edition. CV Mosby. St. Louis. 1982
(39] PALATIANOS. G.M.. DEWANJEE. M.K.. and ROBINSON. R.P.. et al. Quantification of platelet loss with
Indium-111 labelled platelets in a hollow-fiber membrane oxygenator and arterial filter durmg extracorporeal
circulation in a pig model. Trans. Amer. Soc. Artif. Int. Organs. 35. 1989. pp. 667 — 670
(40] SCHOEN. F.J.. ANDERSON. J.M., DIDISHEIM. P.. DOBBINS. J.J.. GRlSTINA. A.G.. HARASAKI. H., and
SIMMONS. R.L., Ventricular assist device (VAD) pathology analyses: guidelines for clinical studies. J. Appl.
Mater., 1. 1990. pp. 4 9 — 56
(41] SCHOEN. F.J.. Interventional and surgical cardiovascular pathology. Appendix: Pathologic analysis of the
cardiovascular system and prosthetic devices. W.B. Saunders Co.. Phildelphia. 1989, pp. 369 — 396
(42] ROSENGART. T.K.. LANG. S.J.. Valvular Heart Disease. In. Barrie. P.S.. Shires. G.T.. Surgical Intensive Care.
Little. Brown and Company. Boston. 1993. pp. 577 — 612
(43] ANDERSON. J.M.. Cardiovascular Device Retrieval and Evaluation. In: Harker. L.A.. Ratner. B.D., Didisheim, P.
(Eds). Cardiovascular Biomaterlals and Biocompatibllity. Supplement to Cardiovasc. Pathol.. 2. (3) (Suppl.). Jul-
Sept 1993. pp. 199S — 208S
(44] SPENCER. P.C., SCHMIDT. B.. SAMTLEBEN. W.. BOSCH, T. and GURLAND. H.J., Ex vivo model of
hemodialysis membrane biocompatiMity. Trans. Amer. Soc. Artif. Int. Organs. 31.1985. pp. 495 — 498
(45] Tripartite Biocompatibllity Guidance for Medical Oevices. Prepared by toxicology sub-group of the Tripartite
Subcommittee on medical devices. September 1986
(46]WARD. R.A., SCHMIDT. B.. BLUMENSTEIN. M.. and GURLAND. H.J. Evaluation of phagocytic cell function in an
ex vivo model of hemodialysis. Kidney International. 37. 1990. pp. 776 — 782
(47]WHITE. R.A.. Diagnosis and therapy of emergent vascular diseases. In: Shoemaker. W.C.. Ayres, S., Holbrook.
P.R.. and Thompson. W.L., Textbook of Cntical Care. 2nd edn. W.B. Saunders. Philadelphia. 1989. pp. 44 7 — 452
(48] ZINGG. W.. IP. W.F., SEFTON. M.V., and MANCER. K.. A chronic arteriovenous shunt for the testing of
biomaterlals and devices In dogs. Life Support Systems, 4, 1986. pp. 221 — 229
(49] World Health Organization. Recommended methods for the visual determination of white cells and platelet counts.
Document WH0.1AB/88.3. 1988
25